Wednesday, August 26, 2026

Indices

2 articles

SOXX Up 79% YTD as AI Semiconductor Supercycle Expands Beyond Data Centers

SOXX Up 79% YTD as AI Semiconductor Supercycle Expands Beyond Data Centers

The iShares Semiconductor ETF gained 79% year-to-date and 152% over one year as of June 5, 2026, with the 2x leveraged proxy adding 196% over the same window. The trade is broadening from hyperscaler hardware into edge AI, quantum computing, and satellite compute—extending the supercycle's runway. Geopolitical fracture and rising ASIC design costs are reshaping the competitive landscape but have not reversed the trend.

LM Salvado
Semiconductor Index Hits Record High as AI Memory Shortage Triggers 3-4% Supply Gap Through 2026

Semiconductor Index Hits Record High as AI Memory Shortage Triggers 3-4% Supply Gap Through 2026

Semiconductor indices reached all-time highs despite a persistent 3-4% DRAM and NAND shortage through 2026, driven by Nvidia-led AI infrastructure demand. High-bandwidth memory requirements for AI workloads are straining manufacturing capacity, creating premium pricing opportunities for memory suppliers. Intel's 18A process and Micron's US fab expansions aim to capture AI-era supply constraints worth billions.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com